 DUBLIN, Ireland and TREVOSE, Pa., Feb. 03, 2021 GLOBE NEWSWIRE -- Strongbridge Biopharma plc, Nasdaq: SBBP, a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that it has approved inducement equity awards to ten individuals who have recently become, or are expected to become, employees of the Company. 